CSNK1A1 and malignant colon neoplasm: Previously, CK1-specific inhibitors already showed promising effects on colon cancer cell lines and therefore, also inhibitors 20, 21, and 22 were subsequently tested on colon cancer cell lines HCT-116, HT-29, SW480, and SW620.